Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
Ralph A Gruppo |
Hemophilia And Thrombosis Center |
Cascade Hemophilia Consortium (Hemophilia Foundation of Michigan) |
Gruppo, CHC/HFM |
06/01/2003 - 05/31/2018 |
$114,597 |
Adrienne Hammill, MD |
Trial of Sirolimus for Cognitive Impairments in Sturge-Weber syndrome |
National Institutes of Health (Kennedy Krieger Research Institute) |
U54 NS065705 |
08/01/2016 - 07/31/2019 |
$39,624 |
LaQuita M Jones, DO |
Efficacy of Novel FLT3 Inhibitor in Tyrosine Kinase Domain FLT3 AML Mutants |
St. Baldrick's Foundation |
524748 |
07/01/2017 - 06/30/2019 |
$78,498 |
Patrick McGann, MD, MS |
Maximizing Fetal Hemoglobin Responses to Hydroxyurea using Precision Medicine |
Doris Duke Charitable Foundation |
2017090 |
09/01/2017 - 08/31/2020 |
$330,000 |
Patrick McGann, MD, MS |
Therapeutic Response Evaluation and Adherence Trial: A Prospective Study of Hydroxyurea for Children with Sickle Cell Anemia |
National Institutes of Health |
K23 HL128885 |
09/01/2015 - 05/31/2020 |
$188,112 |
Eric Mullins, MD |
Mechanisms Linking Hemostatic Factors and Neuroinflammatory Disease |
American Society of Hematology |
Mullins, Eric, ASH |
03/01/2018 - 02/28/2019 |
$150,000 |
Eric Mullins, MD |
Genotype and phenotype Analysis of Adolescents with Heavy Menstrual Bleeding and low von Willebrand activity |
Baylor College of Medicine |
Mullins, Eric, Baylo |
09/01/2017 - 08/31/2020 |
$5,000 |
Joseph S Palumbo, MD |
Hemostatic Factors Drive Prostate Cancer Pathogenesis |
National Institutes of Health |
R01 CA193678 |
04/15/2016 - 03/31/2021 |
$356,850 |
Joseph S Palumbo, MD |
Coagulation Factors as Modifiers of the Colon Cancer Microenvironment |
National Institutes of Health |
R01 CA204058 |
04/05/2016 - 03/31/2021 |
$356,850 |
Charles T Quinn, MD
Jeffrey A Towbin, MD
Punam Malik, MD |
Cincinnati Center of Excellence in Hemoglobinopathies Research |
National Institutes of Health |
U01 HL117709 |
06/01/2016 - 05/31/2019 |
$659,602 |
Charles T Quinn, MD |
Dissemination and Implementation of Stroke Prevention Looking at the Care Environment (DISPLACE) |
National Institutes of Health (Medical University of South Carolina) |
R01 HL133896 |
08/01/2017 - 06/30/2022 |
$38,120 |
Allison S Remiker, MD |
Mechanisms Linking Fibrin(ogen) Structure/Function to Tumor Metastasis |
American Society of Hematology |
2017ASH |
07/01/2017 - 06/30/2018 |
$70,000 |
Lisa M Shook |
Sickle Treatment and Outcomes Research in the Midwest (STORM) |
Health Resources & Services Admin |
U1EMC27863 |
09/01/2017 - 08/31/2021 |
$612,620 |
Lisa M Shook |
Cincinnati Sickle Cell Project |
Ohio Department of Health |
0310011SK1017 |
07/01/2016 - 06/30/2021 |
$125,956 |
Lisa M Shook |
Sickle Cell |
Ohio Department of Health |
03130011SK1118 - Del |
07/01/2017 - 06/30/2021 |
$33,750 |
Cristina Tarango, MD |
ATHN Data Quality Counts 9.1 |
American Thrombosis & Hemostatis Network |
433 |
07/01/2017 - 06/30/2018 |
$19,500 |
Cristina Tarango, MD |
Community Counts: Public Health Surveillance for Bleeding Disorders |
Ctr for Disease Control and Prevention (Hemophilia Foundation of Michigan) |
CDC 16-17-433 |
09/30/2016 - 09/29/2020 |
$27,250 |
Cristina Tarango, MD |
Hemophilia and Thrombosis Center |
Hemophilia Foundation of Michigan |
Tarango, CHC,HFM |
06/01/2018 - 05/31/2023 |
$114,597 |
Cristina Tarango, MD |
Region V East Comprehensive Care Network for Bleeding Disorders |
Maternal & Child Health Bureau (Hemophilia Foundation of Michigan) |
MCHB 433 18-19 |
06/01/2016 - 05/31/2021 |
$44,000 |
Cristina Tarango, MD |
Prospective Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) |
National Institutes of Health (All Childrens Resesearch Inst., Inc.) |
U01 HL130048 |
01/11/2017 - 06/30/2021 |
$6,374 |
Russell Ware, MD, PhD |
Genetic Variants influencing the Phenotypic Expression of Sickle Cell Anemia |
Doris Duke Charitable Foundation |
2015132 |
09/01/2015 - 08/31/2018 |
$285,207 |
Russell Ware, MD, PhD |
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia |
National Institutes of Health |
U01 HL133883 |
08/01/2017 - 07/31/2022 |
$769,765 |
Total Annual Grant Award Dollars |
$4,426,272 |